SRTS Sensus Healthcare, Inc.
USHealthcareAs of 2026-07-10 16:00
Why SRTS matters now
Sensus Healthcare, Inc. (SRTS) is a US stock in Healthcare. The latest InvestLog snapshot shows $3.05 with +4.45% on the session and $50.2M in market capitalization; recent performance reads 1-month -16.72% and YTD -29.90%.
The latest financial table shown here is Q1 2026, with revenue of $3.4M, net income of $-2.6M, and EPS of $-0.16. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -1.4%.
The latest indexable market news headline is "Sensus Healthcare Q1 Earnings Call Highlights" from MarketBeat.
Additional event context on this page matters because analyst consensus is Buy with a median target of $6.25; recent insider activity includes Sachetta Eric filing P-Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
1.01
P/S
2.04
EV/EBITDA
-3.50
DCF Value
$3.21
FCF Yield
-1.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
37.7%
Operating Margin
-53.3%
Net Margin
-34.5%
ROE
-15.8%
ROA
-15.1%
ROIC
-17.8%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $3.4M | $-2.6M | $-0.16 |
| Q4 2025 | $4.9M | $-3.2M | $-0.19 |
| FY 2025 | $27.5M | $-7.7M | $-0.47 |
| Q3 2025 | $6.9M | $-943.0K | $-0.06 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$6.25
Target (Median)
$6.25
Target Range
$6.00 - $6.50
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.09
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.